Andrea Tu, Author at Bolt Biotherapeutics

Past Events

Advances in Immuno-oncology USA CongressOct 8-9, 2019 | San Diego, [...]

By Andrea Tu|2020-08-27T20:17:44-07:00September 19, 2019|events|Comments Off

Bolt invited to present: World ADC Oct. 8-11, 2019 | San [...]

By Andrea Tu|2020-08-27T20:19:12-07:00September 19, 2019|events|Comments Off

Bolt invited to present: BioScience Forum Sept 18, 2019 | [...]

By Andrea Tu|2020-08-27T20:18:19-07:00September 12, 2019|events|Comments Off

Randall Schatzman, Ph.D., joins Bolt Biotherapeutics as CEO and a [...]

By Andrea Tu|2020-08-27T18:54:41-07:00September 4, 2019|press release|Comments Off

A trailblazing immunotherapy leads to the founding of Bolt Biotherapeutics [...]

By Andrea Tu|2020-08-27T18:56:16-07:00August 6, 2019|media coverage|Comments Off

Bay Area Biotech Bets on Antibodies Armed with Immunostimulant to [...]

By Andrea Tu|2020-08-27T18:57:29-07:00April 18, 2019|media coverage|Comments Off

TLR7/8 immune stimulating antibody conjugates elicit robust myeloid activation and [...]

By Andrea Tu|2020-10-12T13:14:00-07:00April 9, 2019|publications|Comments Off

Bolt Biotherapeutics Presents Preclinical Proof of Concept Data at American [...]

By Andrea Tu|2020-08-27T18:57:55-07:00April 1, 2019|press release|Comments Off

Bolt Biotherapeutics Completes $54 Million Series B Financing

By Andrea Tu|2020-08-27T18:58:20-07:00February 5, 2019|press release|Comments Off

Systemic Immunity is Required for Effective Cancer Immunotherapy Spitzer MH, [...]

By Andrea Tu|2020-10-12T15:57:27-07:00February 5, 2019|publications|Comments Off